Comparative Pharmacology
Head-to-head clinical analysis: CONSTILAC versus PLENVU.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CONSTILAC versus PLENVU.
CONSTILAC vs PLENVU
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Constilac (lactulose) is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids (e.g., lactic acid), which osmotically draw water into the bowel, producing a laxative effect. Additionally, in hepatic encephalopathy, the acidification of colonic contents traps ammonia (NH3) as ammonium (NH4+), reducing its absorption.
PLENVU is an osmotic laxative that induces bowel cleansing by causing water retention in the colon, leading to increased intraluminal pressure and stimulation of peristalsis. Its components (polyethylene glycol 3350, sodium ascorbate, ascorbic acid, sodium sulfate) act synergistically to produce a cathartic effect.
Oral, 15-45 mL (10-20 g lactulose) once daily, titrated to produce 2-3 soft stools daily; may be given as a single dose or divided twice daily. Onset of action 24-48 hours.
2 sachets (each containing ascorbic acid 4.7g, macrogol 3350 52.5g, sodium ascorbate 5.9g, sodium sulfate 3.75g) dissolved in water to a total volume of 500mL, administered orally as a split-dose regimen: first dose (2 sachets in 500mL water) at 6-9 pm on the day before colonoscopy, followed by additional 500mL of clear fluids; second dose (2 sachets in 500mL water) on the morning of colonoscopy, completed at least 2 hours before the procedure, followed by additional 500mL of clear fluids.
None Documented
None Documented
Not applicable due to negligible systemic absorption; lactulose acts locally in the colon.
Not applicable (non-absorbed agent); systemic absorption is minimal, so no terminal half-life is defined.
Primarily fecal as unchanged drug (systemic absorption negligible). Renal excretion accounts for <2% of any absorbed fraction. Biliary excretion is minimal.
Primarily fecal (90-95%) as unabsorbed drug; renal excretion is negligible (<1%).
Category C
Category C
Osmotic Laxative
Osmotic Laxative